On 3-4 June, ahead of the 2021 G7 Meeting hosted by the UK, the University of Oxford was chosen as the seat of the G7 Health Ministers’ Meeting to discuss measures for strengthening global health security and improving resilience against future pandemics.
On the margins of the meeting, the Blavatnik School of Government hosted a public event on The Future of Global Health, to discuss insight from our Programme on International Peace and Security (IPS)’s research into Public Health and National Security after COVID-19. The project is the result of a partnership between IPS and the US National Defense University Center for the Study of Weapons of Mass Destruction (CSWMD), and is generously supported by the University’s Research and Policy Partnership Scheme. Our former fellow (now research consultant) Nima Gerami and IPS Executive Director Federica D’Alessandra (PI) are leading the research partnership with Dr Amanda Moodie (US Department of Defense).
The panel discussion, which brought together leading experts and policymakers in health security and biological preparedness, explored the challenges and opportunities for building a more effective global health architecture, and the imperative of avoiding a ‘two-track pandemic’.
Federica D’Alessandra and Dr Moodie took part to the discussion, alongside Jo Wolff, Professor of Values in Public Policy and Director of the Alfred Landecker Programme at Blavatnik School, and Piers Millett, Senior Research Fellow, Future of Humanity Institute, University of Oxford.
During the discussion, Dr Moodie, a leading US expert on biosecurity and Policy Fellow at CSWMD, presented some preliminary findings from our forthcoming paper on the policy trade-offs of securitizing infectious disease, which will be published in the next weeks.